The objective of this study is to constitute cohorts of IBD versus non-IBD patients to identify (a) new biomarker(s) of intestinal dysbiosis associated with inflammatory bowel disease, and develop a prototype for assaying such marker(s) in blood.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
120
Collection of biological samples from the same cohorts: faeces, serum, intestinal biopsies
CHU de Liège
Liège, Belgium
RECRUITINGNumber of patients recruited in each cohort
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
number of faeces samples collected in each cohort
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
Number of plasma samples collected in each cohort
60 patients in IBD cohort and 60 patients in control cohort
Time frame: 27 months
Number of biopsy samples collected in each cohort
60 patients in IBD cohort and 60 patients in control cohort with 4 colonic biopsies/ patient
Time frame: 27 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.